HCW BIOLOGICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.11 USD | -0.89% |
|
-13.28% | -9.39% |
| 01/04 | HCW Biologics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 01/04 | HCW Biologics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart calendar HCW Biologics Inc.
e7a90.RAIRttrn6bboaElk0fwGyyu8buGon2qKhJpXuI0Ak8w.CE9H84jQmNy_BgYBqKh0jmbGHoafrR3kzs0cwt5TqqENY1_YtLS5gI47CA~550f4dd8a0b6265826d828c3a2f4d258
Upcoming events on HCW Biologics Inc.
Past events on HCW Biologics Inc.
| 09/05/2024 | Q1 2024 Earnings Release (Projected) |
| 02/04/2024 01:40 am | Q4 2023 Earnings Release |
| 14/11/2023 05:30 pm | Q3 2023 Earnings Release |
| 03/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Poster No - 767 |
| 11/09/2023 04:30 pm | H.C. Wainwright Global Investment Conference - Pre recorded |
| 11/08/2023 04:30 pm | Q2 2023 Earnings Release |
| 22/06/2023 07:30 pm | Maxim Group Virtual Healthcare Conference |
| 13/06/2023 07:30 pm | Annual General Meeting |
| 09/05/2023 04:45 pm | Q1 2023 Earnings Release |
| 18/04/2023 06:30 pm | American Association for Cancer Research Meeting - Abstract No - 4441 |
| 29/03/2023 01:55 am | Q4 2022 Earnings Release |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Poster 724 |
| 08/11/2022 03:15 am | Q3 2022 Earnings Release |
| 12/08/2022 04:30 pm | Interim 2022 Earnings Release |
| 15/06/2022 07:30 pm | Annual General Meeting |
| 13/05/2022 04:45 pm | Q1 2022 Earnings Release |
| 10/05/2022 03:00 am | American Association of Immunologists Immunology Meeting - Abstract Number : 2389 |
| 09/05/2022 09:38 pm | American Association of Immunologists Immunology Meeting - Abstract Number : 2442 |
| 09/05/2022 03:00 am | American Association of Immunologists Immunology Meeting - Abstract Number : 2442 |
| 20/04/2022 01:30 am | CED Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 4,10 | 0,00 0,00 - | 6,72 5,39 24.7% | 2,84 1,52 87.21% | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -13,2 -13,5 1.92% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -13,4 -14,5 7.58% | -15,1 -14,7 -2.6% | -25,7 -20,4 -25.82% | -23,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,9 -13,9 7.22% | -14,9 -14,2 -5.21% | -25,0 -19,8 -26.2% | -23,9 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -12,9 -14,8 13.23% | -14,9 -14,7 -1.15% | -25,0 -19,8 -26.2% | -23,9 |
|
EPS USD | Released Forecast Spread | -0,64 | -0,69 -0,77 9.8% | -0,42 -0,42 -1.2% | -0,70 -0,55 -27.27% | -0,57 |
| Announcement Date | 26/05/21 | 29/03/22 | 28/03/23 | 01/04/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 3,12 0,00 - | 0,45 0,00 - | 1,81 0,00 - | 1,34 0,00 - | 0,04 0,00 - | 0,62 0,00 - | 0,85 0,00 - | 1,32 0,00 - |
|
EBITDA Million USD | Released Forecast Spread | -3,55 -4,50 21.04% | -5,12 -5,40 5.19% | -4,80 -5,20 7.64% | -4,23 -5,30 20.26% | |||||
|
EBIT Million USD | Released Forecast Spread | -3,11 -4,19 25.66% | -1,88 -5,00 62.38% | -3,51 -4,58 23.39% | -4,02 -4,60 12.64% | -5,67 -5,29 -7.12% | -4,51 -5,17 12.82% | -5,08 -4,65 -9.13% | -10,8 -5,49 -96.11% | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,17 -4,17 23.97% | -2,75 -4,07 32.36% | -3,91 -4,30 9.04% | -5,42 -4,68 -15.76% | -4,30 -5,17 16.81% | -4,94 -4,65 -6.14% | -10,7 -5,49 -94.51% | ||
|
Net income Million USD | Released Forecast Spread | -3,17 -4,17 23.97% | -3,51 -4,58 23.4% | -3,91 -4,60 14.94% | -5,42 -5,24 -3.4% | -5,07 -5,70 11.04% | -4,30 -5,17 16.81% | -4,94 -4,65 -6.14% | -10,7 -5,49 -94.51% | |
|
EPS USD | Released Forecast Spread | -0,09 -0,12 25% | -0,06 -0,11 45.45% | -0,10 -0,13 20% | -0,11 -0,13 15.38% | -0,15 -0,15 -3.45% | -0,14 -0,16 12.5% | -0,12 -0,16 22.58% | -0,14 -0,13 -7.69% | -0,30 -0,15 -100% |
| Announcement Date | 29/03/22 | 13/05/22 | 12/08/22 | 07/11/22 | 28/03/23 | 09/05/23 | 11/08/23 | 14/11/23 | 01/04/24 |
| 15/05/2024 | CELCUITY INC.: Q1 2024 Earnings Release |
| 16/05/2024 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 16/05/2024 06:30 pm | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 24/07/2024 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 25/07/2024 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 25/07/2024 10:30 am | ARGENX SE: Q2 2024 Earnings Release |
| 30/07/2024 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 30/07/2024 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for HCW Biologics Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HCWB Stock
- Calendar HCW Biologics Inc.